Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation
Objectives: To evaluate the clinical effectiveness (including adverse events) and cost-effectiveness of antivirals for the treatment of naturally acquired influenza for ‘at-risk’ and otherwise healthy populations. Data sources: Eleven electronic databases (MEDLINE, EMBASE, Cumulative Index to Nursin...
Main Authors: | J Burch, M Paulden, S Conti, C Stock, M Corbett, NJ Welton, AE Ades, A Sutton, N Cooper, AJ Elliot, K Nicholson, S Duffy, C McKenna, L Stewart, M Westwood, S Palmer |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2009-11-01
|
Series: | Health Technology Assessment |
Subjects: | |
Online Access: | https://doi.org/10.3310/hta13580 |
Similar Items
-
In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients
by: Emi Takashita, et al.
Published: (2020-09-01) -
Clinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza
by: Naomi Bradbury, et al.
Published: (2018-05-01) -
Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11
by: Katrina Sleeman, et al.
Published: (2011-11-01) -
Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
by: Yacine Abed, et al.
Published: (2019-04-01) -
Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017
by: Toledo-Rueda W, et al.
Published: (2018-10-01)